Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01110733 · ClinicalTrials.gov registry record
Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry
A clinical trial, sponsored by Acrotech Biopharma.
- Completed
- Registry status
- 3,000
- Enrollment target
NCT01110733 is a clinical trial that has completed, run by Acrotech Biopharma. The registered enrollment target is 3,000 participants.
The verdict
NCT01110733 has completed, sponsored by Acrotech Biopharma.
- COMPLETED
- Registry status
- 3,000 participants
- Enrollment target
Study Summary
Prospective, longitudinal, multinational, observational study that will collect data on how patients with peripheral T-cell lymphoma (PTCL) are treated in academic and community practices.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2010-02 |
| Est. Completion | 2019-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01110733
The ClinicalTrials.gov registry entry for NCT01110733 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 3,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Acrotech Biopharma, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01110733 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01110733 about?
NCT01110733 is a clinical study titled "Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry". Prospective, longitudinal, multinational, observational study that will collect data on how patients with peripheral T-cell lymphoma (PTCL) are treated in academic and community practices.
What is the current status of trial NCT01110733?
This trial is currently completed. The enrollment target is 3,000 participants. The study started on 2010-02. Estimated completion is 2019-12.
Who is sponsoring clinical trial NCT01110733?
This trial is sponsored by Acrotech Biopharma, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.